Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've searched for a free online training course about Mounjaro, you've probably already noticed how crowded that space is. Let's get the most important point out of the way first: no online course or training module, free or paid, can prescribe Mounjaro, assess your suitability for it, or substitute for clinical oversight. What these resources can do is help you understand how tirzepatide works, why clinical assessment matters, and what to expect from treatment — and that's genuinely useful. Mounjaro (tirzepatide) is a Prescription-Only Medicine; a qualified prescriber must review your individual circumstances before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's an easy assumption to reach, you find a thorough-looking free module, work through it, feel well-informed, and conclude that's the green light. It isn't, and it's worth saying so gently rather than letting it go unexamined. A training course, however well produced, gives you information about tirzepatide in general. It cannot assess your medical history, your current medications, or whether this particular treatment fits your situation right now. That assessment is the prescriber's job, and under UK law it's a required step, not an optional one.
The good news is that arriving at a consultation already knowing the basics (how the dual-agonist mechanism works, what the dose progression looks like, which side effects to watch for) makes that conversation more productive. You can ask better questions. Our clinical team, which you can read more about on the clinical team profile page, finds that well-prepared patients tend to get more from their first consultation.
So the right frame for any free Mounjaro training course is: useful preparation, not a gateway to treatment. Keep that distinction in mind as you evaluate what you're reading.
Quality educational content on Mounjaro tends to cover a handful of core topics. The mechanism is usually the starting point: tirzepatide acts on both GIP and GLP-1 receptors, which together reduce appetite, slow how quickly the stomach empties, and influence how the body handles blood sugar. This dual-action profile is what sets Mounjaro apart from older GLP-1-only medicines, as the NHS explains in its tirzepatide overview.
Reputable resources also cover the dose schedule, treatment begins at 2.5 mg, a starting dose chosen primarily to let the body adjust, with steps upward typically every four weeks under prescriber guidance. Side effects get serious attention too: nausea, constipation, reflux, and fatigue are the most commonly reported, usually most noticeable after a dose change and often settling within a week or two. Safe injection technique, proper storage (refrigeration at 2–8°C, with a limited room-temperature window detailed in the Patient Information Leaflet), and what to do if a dose is missed are all standard content in professional training materials.
Where things get murkier is in the free-to-access tier. Some resources are accurate; others recycle out-of-date information, confuse Mounjaro with Ozempic, or underplay the clinical-assessment requirement. A page on what a structured Mounjaro course covers can help you benchmark what you're reading against a professional standard.
For patients, the clearest free educational material comes from the NHS, NICE, and the manufacturer. The NHS medicines page for tirzepatide is a good baseline: plain language, clinically reviewed, regularly updated. NICE's technology appraisal of tirzepatide (TA1026) is more technical but publicly available if you want to understand the evidence base behind the UK recommendation. Eli Lilly's UK site carries patient-facing information about the KwikPen, storage, and the licensed use case.
For healthcare professionals, accredited training exists through bodies like the MHRA, GPhC-registered training providers, and NHS England pathways, these are distinct from the patient-education resources above and carry formal CPD recognition. If you're a clinician looking for that layer, our page on Mounjaro training for UK healthcare professionals covers what's available and what's recognised.
One practical point worth knowing: weight training and physical activity sit alongside, not against, Mounjaro treatment. Preserving lean muscle while losing weight is something our prescribers discuss regularly; there's a fuller look at this on the Mounjaro and weight training page if that's relevant to your situation.
Once you feel informed about Mounjaro (what it does, what to expect, what's required) the next step is a clinical consultation. In the UK, the only legal route to a Mounjaro prescription is through a licensed prescriber who has assessed your individual suitability, and if you'd like to see how that process works end to end, our page on getting Mounjaro online walks through what a regulated consultation involves.
For context on costs, a breakdown of typical UK Mounjaro pricing sets out what private treatment involves and what a legitimate price should include. Separately, if you're wondering whether NHS access might apply to you, the page on getting Mounjaro through NHS channels explains the phased eligibility criteria honestly.
At nume, consultations are reviewed by a GPhC-registered Independent Prescriber, a real clinician, not a software system. If you'd like to understand the treatment landscape more broadly first, the weight-loss treatments overview is a calm starting point before you make any decisions. When you're ready to take the next step, check your eligibility with our prescribers at no charge.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.